Consolidated Statements of Operations and Comprehensive Income - USD ($)		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Total revenues, net		$ 205,415,542	$ 193,542,423
Cost of revenues (including cost of revenues from a related party of $8,472,202 and $2,842,588 for the years ended December 31, 2024 and 2023, respectively)		49,365,035	56,238,385
Gross profit		156,050,507	137,304,038
Operating expenses:
Selling, general and administrative expenses		57,665,140	66,234,942
Stock-based compensation		13,022,692
Impairment loss on intangible asset		15,058,965
Misappropriation loss			409,030
Total operating expenses		85,746,797	66,643,972
Income from operations		70,303,710	70,660,066
Other income (expenses):
Interest income		19,943	86,748
Interest expense		(28,300)	(45,292)
Other income (including other income from related parties of $2,673,077 and nil for the years ended December 31, 2024 and 2023, respectively)		4,810,008	3,623,332
Other expenses		(5,463,153)	(745,519)
Gain on disposal of subsidiary		3,813,609
Total other income		3,152,107	2,919,269
Income before income taxes		73,455,817	73,579,335
Income tax expense		26,765,925	35,018,729
Net income		46,689,892	38,560,606
Less: net income (loss) attributable to non-controlling interests		75,617	(809,430)
Net income attributable to SBC Medical Group Holdings Incorporated		46,614,275	39,370,036
Other comprehensive loss:
Foreign currency translation adjustment		(16,557,607)	(12,855,686)
Reclassification of unrealized gain on available-for-sale debt security to net income when realized, net of tax effect of nil and $3,869 for the years ended December 31, 2024 and 2023, respectively			(8,760)
Total comprehensive income		30,132,285	25,696,160
Less: comprehensive income (loss) attributable to non-controlling interests		117,830	(948,896)
Comprehensive income attributable to SBC Medical Group Holdings Incorporated		$ 30,014,455	$ 26,645,056
Net income per share - basic	[1]	$ 0.48	$ 0.42
Net income per share - diluted	[1]	$ 0.48	$ 0.42
Weighted average shares outstanding - basic	[1]	96,561,041	94,192,433
Weighted average shares outstanding - diluted	[1]	96,561,041	94,192,433
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Total revenues, net		$ 195,173,889	$ 182,738,049
Cost of revenues (including cost of revenues from a related party of $8,472,202 and $2,842,588 for the years ended December 31, 2024 and 2023, respectively)		8,472,202	2,842,588
Other income (expenses):
Other income (including other income from related parties of $2,673,077 and nil for the years ended December 31, 2024 and 2023, respectively)		2,673,077
Nonrelated Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Total revenues, net		$ 10,241,653	$ 10,804,374

[1] Retrospectively restated for effect of reverse recapitalization on September 17, 2024.